MarketPeel
Insider Trading Intelligence
Pricing
…
CL

Casdin Private Growth Equity Fund, L.p.

LAB
DIRECTOR · STANDARD BIOTOOLS INC. · CIK 0001823061
FILING MIX · LIFETIME88%/12%
BUYS
64
SELLS
9
TOTAL VALUE
$211.95M
COMPANIES
3
ACTIVE SINCE
Jul 2021
HOLDINGS NOW
76,298,109
AVG SELL PX
$1.81
TRADE KIND
SHOWING 73 / 73
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
49 backtested trades · 8 horizons · 64 pending
Forward-return performance of every backtestable P/S trade by Casdin Private Growth Equity Fund, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d49+63.27%+4.60%+0.46%+4.14%+2.36%4.23
14d49+75.51%+8.94%+0.92%+8.02%+5.32%5.40
30d49+69.39%+6.58%+2.25%+4.33%+3.05%1.76
60d49+55.10%+5.04%+4.29%+0.75%+1.65%0.34
90d49+36.73%-4.23%+4.91%-9.14%-9.85%-3.20
180d49+4.08%-18.78%+10.42%-28.74%-27.20%-14.48
1y49(24 pending)+4.00%-37.86%+16.45%-54.31%-52.58%—
2y49(40 pending)+0.00%-60.40%+40.73%-101.12%-102.49%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LAB · 72,100,000 shares · as of Dec 4, 2025
018,025,00036,050,00054,075,00072,100,0002025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 64 buys / 9 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LAB
STANDARD BIOTOOLS INC.
PURCHASE
150,000$1.45$217.0K72,100,000Dec 4, 2025Dec 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
75,000$1.44$108.0K71,950,000Dec 3, 2025Dec 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
125,000$1.42$177.5K71,875,000Dec 2, 2025Dec 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
7,550,000$1.30$9.84M71,750,000Nov 25, 2025Nov 26, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
150,000$1.43$214.9K64,200,000Nov 24, 2025Nov 26, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
450,000$1.30$586.3K64,050,000Nov 20, 2025Nov 20, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
350,000$1.28$448.9K63,600,000Nov 19, 2025Nov 20, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
275,000$1.23$339.4K63,250,000Nov 18, 2025Nov 20, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
225,000$1.22$275.6K62,975,000Nov 17, 2025Nov 17, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
250,000$1.24$309.8K62,750,000Nov 14, 2025Nov 17, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
450,000$1.20$541.4K62,500,000Nov 13, 2025Nov 17, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
375,000$1.19$445.8K62,050,000Nov 12, 2025Nov 12, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
300,000$1.20$358.8K61,675,000Nov 11, 2025Nov 12, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
275,000$1.17$321.9K61,375,000Nov 10, 2025Nov 12, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
225,000$1.12$252.8K61,100,000Nov 7, 2025Nov 12, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
100,000$1.29$128.9K60,875,000Sep 9, 2025Sep 11, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
250,000$1.28$319.4K60,775,000Sep 4, 2025Sep 5, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
250,000$1.27$316.4K60,525,000Sep 3, 2025Sep 5, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
125,000$1.26$157.9K60,275,000Aug 26, 2025Aug 26, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
200,000$1.24$248.2K60,150,000Aug 25, 2025Aug 26, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
200,000$1.26$252.7K59,950,000Aug 22, 2025Aug 26, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
150,000$1.22$183.2K59,750,000Aug 15, 2025Aug 15, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
133,220$1.21$161.5K59,600,000Aug 14, 2025Aug 15, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
75,000$1.31$98.3K59,466,780Aug 13, 2025Aug 15, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
4,820,959$1.07$5.13M58,846,780Feb 28, 2025Mar 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
545,000$1.07$580.4K59,391,780Feb 28, 2025Mar 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
SALE
545,000$1.07$580.4K0Feb 28, 2025Mar 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASEGRANT
Stock grant
58,215$1.07$62.0K2,806,470Feb 28, 2025Mar 4, 2025 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
250,000$2.19$546.8K54,025,821Aug 27, 2024Aug 29, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
150,000$2.15$322.5K53,775,821Aug 26, 2024Aug 26, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
292,100$2.13$621.0K53,625,821Aug 23, 2024Aug 26, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
307,900$1.96$602.8K53,333,721Aug 22, 2024Aug 26, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
500,000$1.90$952.0K53,025,821Aug 21, 2024Aug 21, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
500,000$1.87$936.7K52,525,821Aug 20, 2024Aug 21, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
250,000$1.85$463.2K52,025,821Aug 19, 2024Aug 21, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
1,200,000$1.59$1.91M51,775,821Aug 14, 2024Aug 16, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
550,000$1.62$890.6K50,575,821Aug 13, 2024Aug 13, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
500,000$1.64$820.6K50,025,821Aug 12, 2024Aug 13, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
525,408$1.61$848.5K49,525,821Aug 9, 2024Aug 13, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
569,562$1.64$932.6K49,000,413Aug 8, 2024Aug 9, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
500,000$1.57$786.2K48,430,821Aug 7, 2024Aug 9, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
200,000$1.58$316.8K47,930,821Aug 5, 2024Aug 6, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
1,000,000$1.63$1.63M47,730,821Aug 2, 2024Aug 6, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
545,000$2.05$1.12M545,000Jun 18, 2024Jun 21, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
655,000$2.05$1.34M46,730,821Jun 18, 2024Jun 21, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
SALE
1,200,000$2.05$2.46M0Jun 18, 2024Jun 21, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
100,000$2.60$260.0K46,075,821May 23, 2024May 28, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
150,000$2.58$387.7K45,975,821May 22, 2024May 22, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
350,000$2.56$895.9K45,825,821May 21, 2024May 22, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
100,000$2.58$258.1K45,475,821May 20, 2024May 22, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
352,072$2.56$902.0K45,375,821May 17, 2024May 17, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
500,000$2.54$1.27M45,023,749May 16, 2024May 17, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
500,000$2.57$1.28M44,523,749May 15, 2024May 17, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASEGRANT
Stock grant
13,939,637$2.75$38.33M13,939,637Mar 18, 2024Mar 20, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASEGRANT
Stock grant
32,525,821$2.75$89.45M44,023,749Mar 18, 2024Mar 20, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
SALE
89,446$2.75$246.0K0Mar 18, 2024Mar 20, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
SALE
38,334$2.75$105.4K0Mar 18, 2024Mar 20, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
1,403$2.62$3.7K11,497,928Mar 5, 2024Mar 6, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASE
250,000$2.57$642.5K11,496,525Mar 4, 2024Mar 6, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASEGRANT
Stock grant
11,246,525——11,246,525Jan 5, 2024Jan 9, 2024 ↗View →
LAB
STANDARD BIOTOOLS INC.
PURCHASEGRANT
Stock grant
2,744,219——2,744,219Jan 5, 2024Jan 9, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
2,374,849——2,374,849Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
361,969——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
2,012,880——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
361,969——361,969Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
850,000$15.00$12.75M3,224,849Aug 3, 2021Aug 3, 2021 ↗View →
ABSI
ABSCI CORP
PURCHASE
1,562,500$16.00$25.00M6,745,333Jul 26, 2021Jul 28, 2021 ↗View →
ABSI
ABSCI CORP
SALE
1,274,431——0Jul 26, 2021Jul 28, 2021 ↗View →
ABSI
ABSCI CORP
SALE
———0Jul 26, 2021Jul 28, 2021 ↗View →
ABSI
ABSCI CORP
SALE
———0Jul 26, 2021Jul 28, 2021 ↗View →
ABSI
ABSCI CORP
PURCHASE
973,260——5,182,833Jul 26, 2021Jul 28, 2021 ↗View →
ABSI
ABSCI CORP
PURCHASE
4,209,573——4,209,573Jul 26, 2021Jul 28, 2021 ↗View →
ABSI
ABSCI CORP
PURCHASE
973,260——973,260Jul 26, 2021Jul 28, 2021 ↗View →
Other insiders · LAB
Loading peer insiders…
About this filer
CIK 0001823061
ROLE
Director
PRIMARY
LAB
COMPANIES
3
ACTIVE SINCE
Jul 2021
MARKETPEEL · /INSIDER/0001823061DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback